Results 131 to 140 of about 11,445 (270)
Inhibition of XPO1 is a promising modality in the treatment of MDS, especially when combined with Venetoclax, which activates mitochondria‐mediated apoptosis and could be a potential target for MDS therapy. ABSTRACT Background Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat.
Xiaohan Liu +8 more
wiley +1 more source
Microbial Primer: Bacterial energy metabolism. [PDF]
Afinanisa Q +4 more
europepmc +1 more source
Medium- and short-chain dehydrogenase/reductase gene and protein families [PDF]
core +1 more source
Diagnostic modulation of subgingival proteomic biomarkers by age and smoking habits in periodontitis
Abstract Background Although age and smoking influence the periodontal proteome, their impact on subgingival biomarkers for diagnosing periodontitis remains unclear. This multicenter study assessed their influence on subgingival proteins for disease detection.
Triana Blanco‐Pintos +8 more
wiley +1 more source
Leptospira glyceraldehyde-3-phosphate dehydrogenase (LiGAPDH): a cell-surface plasminogen binding protein. [PDF]
de Souza MCL +4 more
europepmc +1 more source
Biogenesis of Organelles and Membrane Proteins. [PDF]
Harmey, Matthew A. +3 more
core +1 more source
Abstract Background This study investigates the impact of disruptions in testosterone levels on bone remodeling, root resorption, and periodontal ligament (PDL) during orthodontic tooth movement (OTM) in a pubertal male rat model. Methods Testosterone deficiency was induced through orchiectomy, and the anabolic‐androgenic steroid (AAS, testosterone ...
Caio Luiz Bitencourt Reis +11 more
wiley +1 more source
Catabolic rewiring in cancer impacts dietary interventions. [PDF]
Chinopoulos C.
europepmc +1 more source
ABSTRACT Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer, with a 5‐year survival rate of less than 20% and a high risk of recurrence despite advances in treatment. This study aimed to identify new therapeutic targets to increase the effectiveness of NSCLC treatments.
Rui‐Shi Wei +5 more
wiley +1 more source
Advances in synthetic biology for engineering methylotrophic microbial cell factories. [PDF]
Guo L, Li R, Gao X, Zhao L, Zhang H.
europepmc +1 more source

